EichorEICHOR
Condition: Pediatric Epileptic Syndrome Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Pediatric Epileptic Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Retraining and Control Therapy (ReACT) R33 Phase
NA · 1 location(s) · University of Alabama at Birmingham · NCT06007053A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Phase 3 · 10 location(s) · Praxis Precision Medicines · NCT07019922A Multicenter Pediatric Deep Brain Stimulation Registry
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06585618A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopath
Phase 1/Phase 2 · 15 location(s) · Institut de Recherches Internationales Servier · NCT07227857A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Phase 3 · 61 location(s) · Stoke Therapeutics, Inc · NCT06872125Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT02890641ESIS in Pediatric DRE
Phase N/A · 1 location(s) · Sarah Katie Ihnen · NCT05469373The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial
NA · 1 location(s) · University College, London · NCT06924086Patterns of Neurodevelopmental Disorders
Phase N/A · 1 location(s) · Richard Frye · NCT06213090A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatr
NA · 1 location(s) · University of Alabama at Birmingham · NCT05819268Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
NA · 1 location(s) · University of Alabama at Birmingham · NCT05096273A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Phase 3 · 60 location(s) · Epygenix · NCT04462770
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.